Equity Research, Broker Reports, and media content on MYLAN NV

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about MYLAN NV
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on MYLAN NV. We currently have 0 research reports from 0 professional analysts.

Date Source Announcement
27Dec16 01:00 PRN Journal of the American Medical Association (JAMA) Publishes Mylan and Biocon's Proposed Biosimilar Trastuzumab Phase 3 Data
16Dec16 01:01 PRN Mylan Launches the First Generic for EpiPen® (epinephrine injection, USP) Auto-Injector as an Authorized Generic
01Dec16 02:37 PRN Mylan's Commitment to Stemming the Tide of HIV/AIDS as Strong as Ever
01Dec16 12:10 PRN Technical Reports on Generic Drugs Stocks -- Mylan, Horizon Pharma, Allergan, and Catalent
28Nov16 12:30 PRN Mylan Signs Sub-license Agreement with the Medicines Patent Pool to Increase Access to Hepatitis C Treatment in Developing Countries
09Nov16 09:05 PRN Mylan Reports Third Quarter 2016 Results
03Nov16 01:15 PRN Mylan and Biocon Announce Regulatory Submission for Insulin Glargine Accepted for Review by European Medicines Agency
  • Frequency of research reports

     

  • Research reports on

    MYLAN NV

  • Providers covering

    MYLAN NV